Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
S Afr J Surg ; 62(2): 58-62, 2024 May.
Article in English | MEDLINE | ID: mdl-38838122

ABSTRACT

BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is a useful, minimally invasive intervention in managing complicated hepatic cystic echinococcosis (HCE). This study aims to assess the use of ERCP in a South African HCE cohort with and without human immunodeficiency virus (HIV) co-infection. METHODS: An analysis was performed of patients with HCE who were assessed for surgery and underwent ERCP at a tertiary hospital in South Africa between 2011 and 2023. Demographics, clinical data, imaging characteristics, operative management, and postoperative complications were compared between HIV-negative (HIV-) and HIV-positive (HIV+) cohorts. RESULTS: Of the 91 patients assessed, 45 (mean age 34.6 years, 73.3% females, 23 HIV+) required ERCP. HIV status did not significantly affect cyst characteristics or surgical outcomes. HIV+ patients had a higher incidence of intraoperative bile leaks (p = 0.025). There were 18 patients who underwent preoperative ERCPs, mainly for biliary-cyst complications primarily causing obstructive jaundice. A total of 40 patients required postoperative ERCPs, mainly for bile leaks. There were no ERCP-related mortalities and only one case of pancreatitis. ERCP success rates were comparable in both cohorts, with an overall success rate of 86.7%. CONCLUSION: HIV co-infection did not significantly impact the clinical course or outcomes of cystic echinococcosis (CE) patients undergoing ERCP. Perioperative ERCP proved effective in managing biliary complications of HCE as well as postoperative complications, regardless of HIV status. This study underscores the importance of endoscopic interventions in the comprehensive management of CE.


Subject(s)
Cholangiopancreatography, Endoscopic Retrograde , Echinococcosis, Hepatic , HIV Infections , Humans , Female , Male , Adult , Retrospective Studies , Echinococcosis, Hepatic/surgery , Echinococcosis, Hepatic/epidemiology , Echinococcosis, Hepatic/complications , HIV Infections/complications , South Africa/epidemiology , Middle Aged , Prevalence , Treatment Outcome , Postoperative Complications/epidemiology , Coinfection/epidemiology
2.
S Afr J Surg ; 62(2): 71, 2024 May.
Article in English | MEDLINE | ID: mdl-38838129

ABSTRACT

SUMMARY: The influence of human immunodeficiency virus (HIV) on the severity of hepatic cystic echinococcosis (CE) is uncertain. HIV-modulated immune suppression may increase the risk of contracting CE with less self-limiting disease, more rapid progression, and a higher likelihood of complications. A 30-year-old male with concurrent, untreated HIV underwent surgery for two large, complicated hepatic CE cysts, which were replacing the right hemiliver, and innumerable peritoneal daughter cysts. At operation, 30 kg of cystic material was removed from the liver and peritoneal cavity. Despite postoperative complications, including cardiac arrest, respiratory failure, and a bile leak, the patient made a full recovery.


Subject(s)
Echinococcosis, Hepatic , HIV Infections , Humans , Male , Adult , HIV Infections/complications , Echinococcosis, Hepatic/complications , Echinococcosis, Hepatic/surgery , Echinococcosis, Hepatic/diagnostic imaging , Coinfection
3.
Acta Paediatr ; 107(8): 1395-1401, 2018 08.
Article in English | MEDLINE | ID: mdl-29476624

ABSTRACT

AIM: Inflammation is a major factor in the pathophysiology of bronchopulmonary dysplasia (BPD), and it contributes to accelerated telomere shortening and cellular ageing. This study aimed to determine its effect on telomere length and lung function in school-aged children born preterm with BPD. METHODS: We examined 29 children with BPD, born preterm in Stockholm county 1998-99, along with 28 children with allergic asthma born at term matched for age and gender. At 10 years of age, we measured relative telomere length (RTL) in blood by quantitative polymerase chain reaction, lung function by spirometry and inflammation by fractional exhaled nitric oxide and blood cytokines. RESULTS: RTL was not different in preterm born with BPD compared to term born children with asthma. The gender effect was strong in both groups; girls had significantly longer median RTL than boys (1.8 versus 1.5, p < 0.01). Short RTL was associated with low forced expiratory flow, also after adjusting for gender, but was not affected by severity of BPD or ongoing inflammation. CONCLUSION: Telomere length was similar in 10-year-old children born preterm with a history of BPD and term born children with allergic asthma. However, impaired lung function and male gender were associated with short telomeres.


Subject(s)
Asthma/genetics , Asthma/physiopathology , Bronchopulmonary Dysplasia/genetics , Bronchopulmonary Dysplasia/physiopathology , Infant, Premature , Telomere/genetics , Age Factors , Asthma/immunology , Case-Control Studies , Cellular Senescence/genetics , Child , Female , Follow-Up Studies , Humans , Infant, Newborn , Inflammation Mediators/analysis , Male , Respiratory Function Tests , Retrospective Studies , Risk Assessment , Sweden , Term Birth
4.
J Perinatol ; 27(7): 422-7, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17476269

ABSTRACT

OBJECTIVE: To study the effects of implementing a method for surfactant administration by transient intubation, INSURE (i.e. INtubation SURfactant Extubation) during nasal continuous positive airway pressure (nCPAP) for moderately preterm infants with respiratory distress syndrome (RDS). STUDY DESIGN: A descriptive, retrospective, bi-center study in Stockholm, Sweden, comparing mechanical ventilation (MV) rates, surfactant use, treatment response and outcome of all inborn infants with gestational age 27 to 34 weeks and RDS, (n=420), during the 5-year periods before and after the introduction of the INSURE-strategy at one of the centers (Karolinska Huddinge) in 1998. The other center (Karolinska Solna) continued conventional surfactant therapy in conjunction with MV throughout the study. RESULTS: Implementation of INSURE at Karolinska Huddinge reduced the number of infants requiring MV by 50% (P<0.01), resulted in earlier surfactant administration and increased overall surfactant use. INSURE-treatment improved oxygenation and the treatment response was sustained over time with only 17% of the infants requiring >1 dose of surfactant. At Karolinska Solna, the MV rates were unaltered between the first and second 5-year period. CONCLUSION: Implementing a strategy of surfactant administration by transient intubation during nCPAP reduces the need for MV without adverse effects on outcome and may be an option to more effectively treat RDS, particularly in a care setting where transfer is necessary to provide MV.


Subject(s)
Continuous Positive Airway Pressure , Infant, Premature , Pulmonary Surfactants/administration & dosage , Respiratory Distress Syndrome, Newborn/therapy , Administration, Inhalation , Follow-Up Studies , Gestational Age , Humans , Infant, Newborn , Intubation , Retrospective Studies
5.
Acta Paediatr ; 92(6): 728-33, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12856986

ABSTRACT

AIM: There is a need for a rapid method to identify infants who will develop respiratory distress syndrome (RDS) soon after birth, to allow early treatment of affected infants with surfactant. The microbubble stability test (MST) may be one such method, but clinical experience is sparse. METHODS: The MST was performed on gastric aspirates from 188 infants with a mean gestational age of 29 (range 23-31) wk. RESULTS: 87 infants developed moderate to severe RDS, corresponding to a prevalence of 46%. The sensitivity, specificity and predictive values for identification of infants with moderate to severe RDS were determined for the average diameter of bubbles, the proportion of microbubbles with different diameters and the total number of microbubbles. The proportion of microbubbles with diameters <20 or 25 microm gave the best prediction, with a sensitivity of 78-79%, a specificity of 57-58%, a positive predictive value of 62% and a negative predictive value of 76%. Early treatment with nasal continuous positive airway pressure probably mitigated the development of RDS in some infants with a low-degree surfactant deficiency and this may explain the relatively low specificity. CONCLUSION: In infants of <32 wk gestation RDS can be predicted by computerized image analysis of the size distribution of microbubbles generated in gastric aspirates.


Subject(s)
Infant, Premature , Respiratory Distress Syndrome, Newborn/diagnosis , Gestational Age , Humans , Infant, Newborn , Intensive Care Units, Neonatal , Positive-Pressure Respiration , Predictive Value of Tests , Pulmonary Surfactants/therapeutic use , Respiratory Distress Syndrome, Newborn/therapy
6.
Toxicology ; 136(1): 1-13, 1999 Aug 13.
Article in English | MEDLINE | ID: mdl-10499846

ABSTRACT

Tricyclic antidepressants can, when taken in overdose, cause serious pulmonary failure such as the adult respiratory distress syndrome (ARDS). In this study we have examined the effects of some tricyclic antidepressants (amitriptyline, imipramine, nortriptyline and desipramine) on the viability and morphology of human endothelial and smooth muscle cells derived from umbilical cord. Effects of amitriptyline on endothelial cell fluidity, as well as permeability changes to an endothelial-smooth muscle cell bi-layer, were also studied. The tricyclic antidepressants induced acute, sub-lethal toxicity in both cell types above 100 microM as assessed by the MTT reduction assay. Morphological changes were also observed at these concentrations. Such changes were, however, absent at 33 microM and below. Amitriptyline did, however, cause a concentration-dependent fall in the electrical resistance of an endothelial-smooth muscle cell bi-layer, with significant effects already evident at 33 microM. All of these observed effects were fairly rapid and appeared within 5-15 min of exposure. The rapidity of these permeabilisation effects suggests potential membrane perturbations, since tricyclic antidepressants are lipophilic molecules with affinity for cell membranes. However, fluorescence anisotropy measurements showed no significant difference in membrane fluidity between amitriptyline-treated and control endothelial cells. Collectively, these data point to specific mechanisms of action of amitriptyline, and probably also the other tricyclic antidepressants studied, on endothelial permeability, which is a hallmark of ARDS. The data suggest that increased endothelial permeability could be due to impaired tight junction function.


Subject(s)
Amitriptyline/toxicity , Antidepressive Agents, Tricyclic/toxicity , Endothelium, Vascular/drug effects , Muscle, Smooth, Vascular/drug effects , Tight Junctions/drug effects , Cell Membrane Permeability/drug effects , Cell Survival/drug effects , Cells, Cultured , Coculture Techniques , Desipramine/toxicity , Electric Impedance , Endothelium, Vascular/pathology , Fluorescent Antibody Technique, Indirect , Formazans/metabolism , Humans , Imipramine/toxicity , Muscle, Smooth, Vascular/pathology , Nortriptyline/toxicity , Spectrometry, Fluorescence , Tetrazolium Salts/metabolism , Tight Junctions/physiology , Umbilical Cord/cytology
7.
Scand J Clin Lab Invest ; 59(4): 259-66, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10463464

ABSTRACT

Human umbilical vein endothelial cells and smooth muscle cells, cultured on either side of fixed, porous supports, were used to study the effect of pro-inflammatory cytokines on the transvascular passage of the drug paracetamol. The cellular bilayer effectively retarded the passage of the drug from the "luminal" or endothelial side, to the "tissue" or smooth muscle side of the bilayer over a 30-min period. When the cells were incubated with either IL-1beta (100 ng/l) or TNF-alpha (10 microg/l) for 4 h prior to exposure to paracetamol, the permeability of the bilayer to the drug increased to that of the control inserts without cells. In contrast, the pro-inflammatory cytokines did not affect the electrical resistance of the bilayer, indicating continued tight junctional integrity, or the passage of [3H]-inulin, an indicator of paracellular transport, or the passage of fluorescein, an indicator of passive diffusion across the cells. Together these data indicate the suitability of this syngenetic human cell co-culture model for studying factors affecting the systemic disposition of drug molecules at the level of the vascular wall. The data also indicate that the transport of paracetamol across the blood vessel wall may be greatly enhanced at sites of tissue inflammation in the systemic circulation.


Subject(s)
Acetaminophen/metabolism , Cell Membrane Permeability , Cytokines/pharmacology , Endothelium, Vascular/metabolism , Lipid Bilayers/metabolism , Muscle, Smooth, Vascular/metabolism , Analgesics, Non-Narcotic/metabolism , Coculture Techniques , Fluorescein/metabolism , Humans , Interleukin-1/pharmacology , Inulin/metabolism , Tritium , Tumor Necrosis Factor-alpha/pharmacology , Umbilical Veins
8.
Lakartidningen ; 96(13): 1571-6, 1999 Mar 31.
Article in Swedish | MEDLINE | ID: mdl-10218338

ABSTRACT

Randomised trials have shown exogenous surfactant therapy to reduce mortality and morbidity among very low birthweight (VLBW) infants with respiratory distress syndrome (RDS). Surfactant therapy is normally given to infants on mechanical ventilation. In the Stockholm area, 12 VLBW infants born after 27-30 gestational weeks and suffering from RDS were recently treated using the INSURE (Intubation-SURfactant-Extubation) approach--i.e., surfactant therapy during brief intubation, immediately followed by extubation and continuous positive airway pressure (CPAP) treatment. The treatment was successful in all 12 cases, the mean (+/- SD) a/A ratio increasing significantly from 0.17 +/- 0.04 before the INSURE procedure to 0.46 (0.12 after (P < 0.001). Only one infant later needed mechanical ventilation for RDS.


Subject(s)
Infant, Very Low Birth Weight/physiology , Intensive Care, Neonatal , Lung/physiology , Positive-Pressure Respiration , Pulmonary Surfactants/administration & dosage , Respiration, Artificial , Respiratory Distress Syndrome, Newborn/drug therapy , Blood Gas Analysis , Female , Humans , Infant, Newborn , Lung/diagnostic imaging , Lung/physiopathology , Male , Pregnancy , Pregnancy Complications/diagnosis , Pregnancy, Multiple , Radiography , Respiratory Distress Syndrome, Newborn/diagnostic imaging , Respiratory Distress Syndrome, Newborn/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...